Institutional Ownership Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI). We have compiled data on the 163 institutions that hold shares in the stock, with a total of 109 Million shares, which have been reported (via 13F filing form) to have a value of $847 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nea Management Company, LLC
Timonium, MD |
Aug 14, 2025 Q2 2025 |
13,222,228
shares
|
$102 Million
6.0% of portfolio
|
Q2 2025
Added 16.29%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
10,259,409
shares
|
$79.4 Million
2.96% of portfolio
|
Q1 2025
Reduced 3.8%
|
|
|
Rubric Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
8,531,860
shares
|
$66 Million
1.08% of portfolio
|
Q2 2025
Added 87.99%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
5,316,691
shares
|
$41.2 Million
0.0% of portfolio
|
Q2 2025
Added 38.53%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
4,487,903
shares
|
$34.7 Million
5.2% of portfolio
|
Q2 2025
Added 28.67%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
4,281,355
shares
|
$33.1 Million
0.01% of portfolio
|
Q2 2025
Added 19064.53%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
4,046,435
shares
|
$31.3 Million
0.13% of portfolio
|
Q2 2025
Added 96.64%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
3,938,793
shares
|
$30.5 Million
1.11% of portfolio
|
Q2 2025
Added 37.54%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,672,000
shares
|
$28.4 Million
7.62% of portfolio
|
Q2 2025
Added 10.54%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
3,406,955
shares
|
$26.4 Million
3.65% of portfolio
|
Q2 2025
Reduced 0.62%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
3,308,400
shares
|
$25.6 Million
0.65% of portfolio
|
Q2 2025
Added 195.39%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,135,115
shares
|
$24.3 Million
0.0% of portfolio
|
Q2 2024
Added 31.97%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
2,534,058
shares
|
$19.6 Million
2.33% of portfolio
|
Q2 2025
Added 102.72%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
2,477,916
shares
|
$19.2 Million
0.02% of portfolio
|
Q2 2025
Reduced 2.99%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
2,354,402
shares
|
$18.2 Million
0.02% of portfolio
|
Q2 2025
Added 33.88%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,144,844
shares
|
$16.6 Million
7.67% of portfolio
|
Q1 2025
Added 7.19%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,832,920
shares
|
$14.2 Million
0.0% of portfolio
|
Q2 2025
Added 28.67%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,786,845
shares
|
$13.8 Million
0.0% of portfolio
|
Q2 2025
Added 10.65%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
1,728,676
shares
|
$13.4 Million
0.02% of portfolio
|
Q2 2025
Reduced 27.0%
|
|
|
Viking Global Investors LP
|
Aug 14, 2025 Q2 2025 |
1,543,000
shares
|
$11.9 Million
0.03% of portfolio
|
Q2 2025
Reduced 52.2%
|
|
|
Mai Capital Management
|
May 15, 2025 Q1 2025 |
1,385,050
shares
|
$10.7 Million
0.07% of portfolio
|
Q1 2025
Added 2.08%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,381,324
shares
|
$10.7 Million
0.14% of portfolio
|
Q2 2025
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,319,266
shares
|
$10.2 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Artia Global Partners LP
Miami, FL |
Aug 14, 2025 Q2 2025 |
1,311,840
shares
|
$10.2 Million
1.73% of portfolio
|
Q2 2025
New holding
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
1,146,110
shares
|
$8.87 Million
5.92% of portfolio
|
Q2 2025
New holding
|